Compensation award — excluded from discretionary-purchase analysis.
Loading…
Traded Sep 4, 2026 · Filed Sep 9, 2026
Zimmer Biomet's See remarks below. sold $295K of Zimmer Biomet shares. It happened by itself, for taxes or pay.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$295,050
Shares × reported transaction price
30 days after results of Aug 5, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $98.07 on Sep 4, 2026, 23% above its 52-week low and 7% below its high, after a 7% rise over the previous 30 trading days
52-week range $79.58 (May 11, 2026) to $105.73 (Sep 5, 2025), 71% of the way up, from 252 adjusted closes. 30 trading days earlier: $91.35 on Jul 24, 2026. Describes the past only, not a forecast
Footnote references dividend reinvestment
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +2.0% | +0.6% | +1.3% |
Past results only. Not a forecast.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
